Report cover image

Left Ventricular Assist Devices Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update

Publisher GlobalData
Published Aug 26, 2024
Length 122 Pages
SKU # GBDT19176698

Description

Left Ventricular Assist Devices Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update


Summary

GlobalData's Medical Devices sector report, “Left Ventricular Assist Devices Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update provides comprehensive information about the Left Ventricular Assist Devices pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

An implantable left ventricular assist device is a ventricular assist system intended for the treatment of end-stage heart failure. It assists the left ventricle by pumping oxygenated blood to the body. It can also be used to treat the right ventricle in some cases.

Note:Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope
  • Extensive coverage of the Left Ventricular Assist Devices under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Left Ventricular Assist Devices and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry
Reasons to Buy

The report enables you to -
  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
  • Identify and understand important and diverse types of Left Ventricular Assist Devices under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product’s current stage of development, territory and estimated launch date

Table of Contents

122 Pages
    • Left Ventricular Assist Devices Overview
    • Left Ventricular Assist Devices - Pipeline Products by Stage of Development
    • Left Ventricular Assist Devices - Pipeline Products by Territory
    • Left Ventricular Assist Devices - Pipeline Products by Regulatory Path
    • Left Ventricular Assist Devices - Pipeline Products by Estimated Approval Date
    • Left Ventricular Assist Devices - Ongoing Clinical Trials
    • Left Ventricular Assist Devices Companies - Pipeline Products by Stage of Development
    • Left Ventricular Assist Devices - Pipeline Products by Stage of Development
    • Abbott Vascular Inc Company Overview
    • Abiomed Inc Company Overview
    • APK Advanced Medical Technologies, Inc. Company Overview
    • Arrow International Cr, A.S. Company Overview
    • Beijing Yuewei Medical Technology Co Ltd Company Overview
    • BioVentrix Inc Company Overview
    • BrioHealth Solutions Inc Company Overview
    • Calon Cardio-Technology Ltd Company Overview
    • Cardiac Success Ltd Company Overview
    • CardiacBooster BV Company Overview
    • CARDIAnove Inc Company Overview
    • Carnegie Mellon University Company Overview
    • Chongqing Yongrenxin Medical Devices Co Ltd Company Overview
    • Cleveland Clinic Hospital Company Overview
    • Cleveland Heart Inc Company Overview
    • CorAssist Cardiovascular Ltd Company Overview
    • Corvion Inc Company Overview
    • CorWave SA Company Overview
    • Duke University Company Overview
    • FineHeart Company Overview
    • Fundacion para la Investigacion Biomedica del Hospital Gregorio Maranon Company Overview
    • Griffith University Company Overview
    • HeartWare International Inc Company Overview
    • Indian Institute of Technology, Kanpur Company Overview
    • Inspired Therapeutics LLC Company Overview
    • Jarvik Heart Inc Company Overview
    • LaunchPoint Technologies Inc Company Overview
    • Leviticus Cardio Ltd Company Overview
    • Levram Medical Systems Ltd Company Overview
    • Magenta Medical Ltd Company Overview
    • Mayo Clinic Company Overview
    • Medtronic Plc Company Overview
    • Nipro Corp Company Overview
    • Percassist Inc Company Overview
    • Perfusion Solution Inc Company Overview
    • PlugMed Heart SAS Company Overview
    • Pumpinheart Ltd Company Overview
    • ReliantHeart, Inc. Company Overview
    • Sree Chitra Tirunal Institute for Medical Sciences & Technology Company Overview
    • Sun Medical Technology Research Corp Company Overview
    • Sunshine Heart Company, Pty. Ltd. Company Overview
    • Suzhou LungShield Medical Tech Co Ltd Company Overview
    • Syntach AB Company Overview
    • Thoratec LLC Company Overview
    • Tokyo Medical and Dental University Company Overview
    • U.S. Stem Cell Inc Company Overview
    • University of Virginia Company Overview
    • VASCOR Inc Company Overview
    • Windmill Cardiovascular Systems, Inc. Company Overview
    • W-Z BIOTECH, LLC Company Overview
    • Yale University Company Overview
    • Aug 12, 2024: Abiomed Celebrates 25 Years of Heart Recovery with Impella
    • May 01, 2024: BrioHealth Solutions Secures Nod from FDA to Begin the INNOVATE Trial Featuring the BrioVAD System for Advanced Heart Failure
    • Apr 15, 2024: Abbott/Thoratec Corp. Recalls HeartMate II and HeartMate 3 Left Ventricular Assist System (LVAS) due to Long-term Buildup Causing an Obstruction
    • Apr 07, 2024: Randomized Controlled Trial Confirms Impella CP Improves Survival in Heart Attack with Cardiogenic Shock
    • Mar 25, 2024: Stony Brook Professor George Leibowitz Assumes Role from Interim Dean Richard L. Edwards
    • Mar 11, 2024: Abbott Recalls HeartMate Touch Communication System for Unintentional Pump Start and Stop
    • Feb 20, 2024: Fineheart Widens International IP Protection for Flowmaker
    • Feb 08, 2024: Teleflex Announces Fourth Quarter 2023 Earnings Conference Call Information
    • Dec 08, 2023: Clinical Trial for World's Smallest Heart Pump
    • Nov 13, 2023: Late-Breaking Data Show an Aspirin-Free Medication Regimen Benefits People with Abbott's HeartMate 3 Heart Pump
    • Oct 25, 2023: Magenta Medical Reports Positive Results for US Early Feasibility Study of Elevate Heart Pump in Providing Temporary Mechanical Circulatory Support During High-Risk PCI Procedures Results presented at TCT 2023 in San Francisco
    • Oct 23, 2023: Abiomed to Highlight Data Analysis Identifying Complex Clinical Profile of Patients Receiving Impella-Supported HRPCI at TCT Symposium
    • Oct 10, 2023: Results from Magenta Medical's US Early Feasibility Study of the World's Smallest and Most Powerful Heart Pump to be Highlighted at TCT 2023
    • Oct 03, 2023: FineHeart Obtains Czech Health Authority Approval to Commence First in Human Clinical Study
    • Sep 28, 2023: PercAssist Announces First Patient Treated in EUREKA Study of PSCA System for Hemodynamic Support in Chronic Heart Failure
    • Methodology
    • About GlobalData
    • Contact Us
    • Disclaimer
How Do Licenses Work?
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.